12:00 AM
 | 
Jul 16, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Recombinant IL-7 regulatory update

The European Commission granted Orphan Drug designation for Cytheris' CYT107 to treat progressive multifocal leukoencephalopathy (PML). The company plans to begin a pivotal Phase...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >